Mortal Covid-19 Case with Fungal Infection
Covid-19 increases the risk of developing opportunistic infections, including fungal infections. The immune system can be compromised by Covid-19 itself and certain immunosuppressive agents and steroids used in Covid-19 treatment [1]. Fungal infections associated with Covid-19 significantly worsen the severity of the disease and increase the risk of death [2, 3]. The most commonly reported fungal infection agents in conjunction with Covid-19 are aspergillus, candida albicans, and mucormycosis [4, 5]. In this case report, we present our patient, a 79-year-old who deteriorated clinically while under Covid-19 follow-up, with positive culture results for aspergillus, candida albicans, and mucormycosis in bronchoalveolar lavage fluid obtained through bronchoscopy, as well as histopathological examination of tissue biopsy from the lesion. Our patient passed away on the 46th day of hospitalization.
Authors
- Ayşegül Karalezli (ORCID: https://orcid.org/0000-0003-3013-4061)
- Hatice Kılıç (ORCID: https://orcid.org/0000-0003-0568-3309)
- Muhammed Furkan Göktaş (ORCID: https://orcid.org/0000-0002-1407-1040)
Publication Details
- Journal
- International Journal of Pulmonology and Disorders
- Published
- 2025-05-05
- DOI
- https://doi.org/10.58489/3066-0955/009
- Citations
- 1
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 1.40